Wednesday, December 29, 2004

From Business Day:
Canadian lawsuit launched against Pfizer
A Canadian law firm has launched a 1.5 billion dollar (1.2 billion US) class action lawsuit against US pharmaceutical company Pfizer, on behalf of a woman who claims she had heart problems after taking Celebrex.

The complaint was tabled by law firm McPhadden Samac Merner Darling against Pfizer Canada et Pfizer Inc., Bryan McPhadden, one of the firm's attorney's said.

The suit accused Pfizer of negligence and claims the lead complainant, a woman from Mississauga, near Toronto, suffered loss of earnings because of health problems allegedly associated with the anti-inflammatory drug.

No comments: